Expression and preliminary application of gene optimized fluorescent antibody against Classical swine fever virus
Hui HE,Xuwen QIAO,Jin CHEN,Xiaoming YU,Yuanpeng ZHANG,Jibo HOU,Qisheng ZHENG,Weidong SUN
DOI: https://doi.org/10.7685/jnau.201605030
2017-01-01
Abstract:[Objectives] The objective of this project is to determined whether the recombinant fluorescent antibody expressed in Escherichia coli can be used to detect Classical swine fever virus (CSFV)in direct immune fluorescence assay.[Methods] The gene VHH-EGFP synthesized according to condon usage of E.coli was cloned into pET32a(+) and then transformed into E.coli BL21 (DE3).The recombinant cells were cultured in LB (containing 50 μg· mL-1 of ampicillin)and incubated in 37 ℃ until A600 =0.6-0.8,then the target gene was induced with 0.4 mmol· L-1 IPTG for 24 h at 15 ℃.The induced bacterial cell pellet was collected and cracked,the interest protein was identified by 120 g· L-1 SDS-PAGE and Western blot,after confirmation,the expressed target protein was purified with Ni-NTA His· Bind Resin and detemined by BCA protein assay kit,and then it was incubated with cells infected with CSFV,PCV2,PRV,PPV to analyze its specificity and sensitivity.[Results] SDS-PAGE and Western-blot indicated that the recombinant fluorescent antibody was successfully expressed in E.coli BL21 (DE3).Although it was mainly expressed as inclusion body form,the soluble protein could be purified and concentrated by nickel column.The PK15 cells infected with CSFV showed numerous obvious green fluorescences points after it was incubated with recombinant antibody.However,there was no or only few nonspecific fluorescence when the recombinant protein incubates with cells infected with PCV2,PRV,PPV.Compared with the IFA based on the commercial monoclonal antibody,the DFA constructed in this study had more sensibility and accuracy.[Conclusions] The optimized VHH-EGFP gene could be efficiently expressed in E.coli BL21 (DE3)system,and the purified recombinant fluorescent antibody was more effective comparable to the commercial monoclonal antibody,and it can be produced with a cheaper and easier process.